7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Myositis, Inclusion Body D018979 3 associated lipids
Atherosclerosis D050197 85 associated lipids
Histiocytosis, Non-Langerhans-Cell D015616 4 associated lipids
Hearing Loss D034381 3 associated lipids
Musculoskeletal Diseases D009140 2 associated lipids
Histiocytosis, Langerhans-Cell D006646 1 associated lipids
Rupture, Spontaneous D012422 1 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
Temporomandibular Joint Disorders D013705 4 associated lipids
beta-Thalassemia D017086 5 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Radicular Cyst D011842 2 associated lipids
Ankylosis D000844 1 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Hyperparathyroidism D006961 3 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Neoplasms, Squamous Cell D018307 1 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Giant Cell Tumor of Bone D018212 1 associated lipids
Jaw Diseases D007571 4 associated lipids
Ossification, Heterotopic D009999 2 associated lipids
Hypercalciuria D053565 4 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Eye Neoplasms D005134 2 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Dengue D003715 2 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Malnutrition D044342 6 associated lipids
Insulin Resistance D007333 99 associated lipids
Hemangioma, Capillary D018324 1 associated lipids
Neoplastic Syndromes, Hereditary D009386 1 associated lipids
Prenatal Exposure Delayed Effects D011297 2 associated lipids
Hot Flashes D019584 5 associated lipids
No-Reflow Phenomenon D054318 2 associated lipids
Vascular Calcification D061205 1 associated lipids
Peri-Implantitis D057873 1 associated lipids
Periodontal Attachment Loss D017622 7 associated lipids
Bone Cysts, Aneurysmal D017824 2 associated lipids
Diabetes Complications D048909 4 associated lipids
Pericardial Effusion D010490 2 associated lipids
Emphysema D004646 1 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Atrial Remodeling D064752 1 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Lithiasis D020347 2 associated lipids
Osteoporotic Fractures D058866 1 associated lipids
Multiple Sclerosis, Chronic Progressive D020528 3 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Hofbauer LC and Heufelder AE The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis. 2001 Arthritis Rheum. pmid:11229454
Leach RJ et al. The genetics of Paget's disease of the bone. 2001 J. Clin. Endocrinol. Metab. pmid:11231972
Hofbauer LC and Heufelder AE [Osteoprotegerin ligand and osteoprotegerin: new concepts of the pathogenesis and therapy of metabolic bone diseases]. 2001 Dtsch. Med. Wochenschr. pmid:11233883
Bolon B et al. Adenoviral delivery of osteoprotegerin ameliorates bone resorption in a mouse ovariectomy model of osteoporosis. 2001 Mol. Ther. pmid:11237676
Sasaki N et al. Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis. 2001 Nephrol. Dial. Transplant. pmid:11239019
Takeuchi T et al. Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells. 2001 Biochem. Pharmacol. pmid:11239501
Mori K et al. Cross-talk between RANKL and FRP-1/CD98 Systems: RANKL-mediated osteoclastogenesis is suppressed by an inhibitory anti-CD98 heavy chain mAb and CD98-mediated osteoclastogenesis is suppressed by osteoclastogenesis inhibitory factor. 2001 Cell. Immunol. pmid:11243701
Michigami T et al. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma. 2001 Cancer Res. pmid:11245477
Wada N et al. Periodontal ligament cells secrete the factor that inhibits osteoclastic differentiation and function: the factor is osteoprotegerin/osteoclastogenesis inhibitory factor. 2001 J. Periodont. Res. pmid:11246705
Lories RJ and Luyten FP Osteoprotegerin and osteoprotegerin-ligand balance: a new paradigm in bone metabolism providing new therapeutic targets. 2001 Clin. Rheumatol. pmid:11254237

Table of Content